Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Drake

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Oncotarget|July 25, 2025
Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancerAiden Deacon, Ava Gustafson, Allison Makovec, et al.
Communications Biology|April 14, 2023
ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystemsHannah E Bergom, Ashraf Shabaneh, Abderrahman Day, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2018
MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in CancerRenée de Leeuw, Christopher McNair, Matthew J Schiewer, et al.
Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of <sup>177</sup>Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.
Arxiv|July 17, 2025
Circulating tumor cell detection in cancer patients using in-flow deep learning holographyKevin Mallery, Nathaniel R Bristow, Nicholas Heller, et al.
NPJ Precision Oncology|August 7, 2025
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancerAllison Makovec, Ella Boytim, Ava Gustafson, et al.
Npj Biosensing|April 17, 2026
Circulating tumor cell detection in cancer patients using in-flow deep learning holographyKevin Mallery, Nathaniel R Bristow, Nicholas Heller, et al.
Cell|August 9, 2016
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate CancerJustin M Drake, Evan O Paull, Nicholas A Graham, et al.
Genes & Development|November 16, 2017
Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockadeHui-Wen Lue, Jennifer Podolak, Kevin Kolahi, et al.
Elife|May 13, 2022
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapiesJustin H Hwang, Rand Arafeh, Ji-Heui Seo, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Oncotarget|July 25, 2025
Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancerAiden Deacon, Ava Gustafson, Allison Makovec, et al.
Communications Biology|April 14, 2023
ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystemsHannah E Bergom, Ashraf Shabaneh, Abderrahman Day, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2018
MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in CancerRenée de Leeuw, Christopher McNair, Matthew J Schiewer, et al.
Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of <sup>177</sup>Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.
Arxiv|July 17, 2025
Circulating tumor cell detection in cancer patients using in-flow deep learning holographyKevin Mallery, Nathaniel R Bristow, Nicholas Heller, et al.
NPJ Precision Oncology|August 7, 2025
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancerAllison Makovec, Ella Boytim, Ava Gustafson, et al.
Npj Biosensing|April 17, 2026
Circulating tumor cell detection in cancer patients using in-flow deep learning holographyKevin Mallery, Nathaniel R Bristow, Nicholas Heller, et al.
Cell|August 9, 2016
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate CancerJustin M Drake, Evan O Paull, Nicholas A Graham, et al.
Genes & Development|November 16, 2017
Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockadeHui-Wen Lue, Jennifer Podolak, Kevin Kolahi, et al.
Elife|May 13, 2022
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapiesJustin H Hwang, Rand Arafeh, Ji-Heui Seo, et al.
Pageof 6